Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Total Current Liabilities (2010 - 2026)

Exelixis (EXEL) posted quarterly Total Current Liabilities of $371.0 million for Q2 2026, down 7.05% year-over-year from $399.1 million in Q2 2025, and down 8.55% quarter-over-quarter from $405.6 million in Q1 2026.

Analysis

Exelixis (EXEL) Total Current Liabilities (2010 - 2026) Analysis & Trends

Exelixis' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $371.0 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities fell 7.05% year-over-year to $371.0 million; the TTM figure through Apr 2026 stood at $371.0 million (down 7.05% YoY), while the FY2026 annual figure was $405.6 million, changed 0.46% from the prior year.
  • Total Current Liabilities for Q2 2026 stood at $371.0 million, down from $405.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $405.6 million in Q1 2026, with the low at $289.1 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $371.0 million (2026), against an average of $356.5 million.
  • The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 35.5% in 2022, then slipped 7.05% in 2026.
  • Exelixis' Total Current Liabilities stood at $324.4 million in 2022, then gained by 21.56% to $394.3 million in 2023, then advanced by 0.02% to $394.3 million in 2024, then dropped by 5.22% to $373.8 million in 2025, then declined by 0.75% to $371.0 million in 2026.
  • Business Quant data shows EXEL's Total Current Liabilities at $371.0 million in Q2 2026, $405.6 million in Q1 2026, and $373.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 361.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 361.93 Mn
Apr 3, 2026 370.98 Mn
Jan 2, 2026 405.64 Mn
Oct 3, 2025 373.78 Mn
Jul 4, 2025 336.11 Mn
Apr 4, 2025 399.10 Mn
Jan 3, 2025 403.77 Mn
Sep 27, 2024 394.35 Mn
Jun 28, 2024 345.70 Mn
Mar 29, 2024 373.01 Mn
Dec 29, 2023 394.28 Mn
Sep 29, 2023 376.82 Mn
Jun 30, 2023 339.62 Mn
Mar 31, 2023 327.60 Mn
Dec 30, 2022 324.36 Mn
Sep 30, 2022 301.73 Mn
Jul 1, 2022 304.52 Mn
Apr 1, 2022 289.08 Mn
Dec 31, 2021 337.59 Mn
Oct 1, 2021 269.51 Mn